[go: up one dir, main page]
IDEAS home Printed from https://ideas.repec.org/p/col/000439/012708.html
   My bibliography  Save this paper

Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano

Author

Listed:
  • Emilio J. Archila
  • Gabriel Carrasquilla
  • Marcela Meléndez
  • Juan Pablo Uribe
Abstract
“El capítulo de la protección a la propiedad intelectual en el sector farmacéutico ha sido uno de los más controvertidos en el contexto de la negociación del TLC con E.E.U.U. Se trata de un delicado porque lo que está en juego es cómo lograr un acuerdo que garantice el balance adecuado entre los incentivos para innovar y los intereses de los consumidores. Este estudio, financiado por la CAF, cumple un doble propósito. Por una parte, establece el impacto que ha tenido el régimen de protección de propiedad intelectual que aplica el sector farmacéutico en Colombia sobre el costo y el acceso a los medicamentos. Por otra, ofrece algunas consideraciones claves para evaluar a futuro el impacto que podrían tener modificaciones a ese régimen. El acercamiento al mercado que se hace en el presente estudio permite mostrar que el impacto de la protección a la propiedad intelectual sobre los precios de los medicamentos no ha sido determinantes y que hay otras imperfecciones del mercado sobre las que las autoridades deben fijar su atención de manera más prioritaria, para defender a los consumidores del ejercicio de poder de mercado por parte de la industria farmacéutica. El capítulo 1 presenta una resena de la literatura para este trabajo. El 2 presenta la aproximación metodológica que establece un conjunto de medicamentos claves para las enfermedades de mayor frecuencia en Colombia. El 3 introduce el régimen de protección que aplica al sector. El 4 presenta un análisis detallado de precios. El 5 analiza los patrones de gasto en medicamentos observados en Colombia y las dinámicas de entrada de nuevos principios activos al mercado. El 6 presenta las conclusiones.”

Suggested Citation

  • Emilio J. Archila & Gabriel Carrasquilla & Marcela Meléndez & Juan Pablo Uribe, 2006. "Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano," Cuadernos de Fedesarrollo 12708, Fedesarrollo.
    • Handle: RePEc:col:000439:012708
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/11445/1917
    Download Restriction: no
    ---><---

    Other versions of this item:

    References listed on IDEAS

    as
    1. Jean O. Lanjouw, 2005. "Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry," Working Papers 61, Center for Global Development.
    2. Lanjouw, Jean O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Center Discussion Papers 28385, Yale University, Economic Growth Center.
    3. En collaboration., 1990. "Strengthening protection of intellectual property in developing countries," World Bank - Discussion Papers 112, World Bank.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Eric W. Bond & Kamal Saggi, 2023. "Compulsory licensing, price controls, and access to patented foreign products," World Scientific Book Chapters, in: Kamal Saggi (ed.), Technology Transfer, Foreign Direct Investment, and the Protection of Intellectual Property in the Global Economy, chapter 19, pages 437-448, World Scientific Publishing Co. Pte. Ltd..
    2. Patricia M. Danzon & Eric L. Keuffel, 2014. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484, National Bureau of Economic Research, Inc.
    3. Gamba, Simona, 2017. "The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector," World Development, Elsevier, vol. 99(C), pages 15-27.
    4. Padmashree Gehl Sampath, 2010. "Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Industry," Working Papers id:3336, eSocialSciences.
    5. Ghauri, Pervez N. & Rao, P.M., 2009. "Intellectual property, pharmaceutical MNEs and the developing world," Journal of World Business, Elsevier, vol. 44(2), pages 206-215, April.
    6. Kamal Saggi, 2016. "Trade, Intellectual Property Rights, and the World Trade Organization," Vanderbilt University Department of Economics Working Papers 16-00014, Vanderbilt University Department of Economics.
    7. Lee Branstetter & Raymond Fisman & C. Fritz Foley, 2005. "Do Stronger Intellectual Property Rights Increase International Technology Transfer? Empirical Evidence from U.S. Firm-Level Data," NBER Working Papers 11516, National Bureau of Economic Research, Inc.
    8. Vishwasrao, Sharmila & Gupta, Srabana & Benchekroun, Hassan, 2007. "Optimum tariffs and patent length in a model of North-South technology transfer," International Review of Economics & Finance, Elsevier, vol. 16(1), pages 1-14.
    9. Billette de Villemeur, Etienne & Ruble, Richard & Versaevel, Bruno, 2014. "Innovation and imitation incentives in dynamic duopoly," MPRA Paper 59453, University Library of Munich, Germany.
    10. Nebibe Varol & Joan Costa-i-Font & Alistair McGuire, 2011. "Explaining Early Adoption on New Medicines: Regulation, Innovation and Scale," CESifo Working Paper Series 3459, CESifo.
    11. Emma Verastegui & Alejandro Mohar, 2010. "Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(1), pages 107-114, January.
    12. Chatterjee, Chirantan & Kubo, Kensuke & Pingali, Viswanath, 2015. "The consumer welfare implications of governmental policies and firm strategy in markets for medicines," Journal of Health Economics, Elsevier, vol. 44(C), pages 255-273.
    13. Kensuke Kubo, 2011. "Explaining vertical integration in the generic pharmaceutical industry," Discussion Papers 11-02, Indian Statistical Institute, Delhi.
    14. Michele Boldrin & David K. Levine, 2013. "The Case against Patents," Journal of Economic Perspectives, American Economic Association, vol. 27(1), pages 3-22, Winter.
    15. Hudson, John & Minea, Alexandru, 2013. "Innovation, Intellectual Property Rights, and Economic Development: A Unified Empirical Investigation," World Development, Elsevier, vol. 46(C), pages 66-78.
    16. Lerner, Josh & Zhu, Feng, 2007. "What is the impact of software patent shifts? Evidence from Lotus v. Borland," International Journal of Industrial Organization, Elsevier, vol. 25(3), pages 511-529, June.
    17. Verniers, Isabel & Stremersch, Stefan & Croux, Christophe, 2011. "The global entry of new pharmaceuticals: A joint investigation of launch window and price," International Journal of Research in Marketing, Elsevier, vol. 28(4), pages 295-308.
    18. Panle Jia & Pinelopi K. Goldberg & Shubham Chaudhuri, 2006. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India," American Economic Review, American Economic Association, vol. 96(5), pages 1477-1514, December.
    19. Ijaz Nabi & Manjula Luthria, 2002. "Building Competitive Firms : Incentives and Capabilities," World Bank Publications - Books, The World Bank Group, number 15220.
    20. N. Lalitha, 2006. "India’s Pharmaceutical Industry in the WTO Regime: A SWOT Analysis," Working Papers id:453, eSocialSciences.

    More about this item

    Keywords

    Industria Farmacéutica; Patentes; Propiedad IndustrialPropiedad Intelectual; Derechos de Patentes; Organización Internacional de la Propiedad Intelectual; Salud Pública; Medicamentos; Productos Farmacéuticos; Precios;
    All these keywords.

    JEL classification:

    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
    • O34 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
    • I10 - Health, Education, and Welfare - - Health - - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:col:000439:012708. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Patricia Monroy (email available below). General contact details of provider: https://edirc.repec.org/data/fedesco.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.